As of 2024-12-12, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (32.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.38 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -611.1%.
The range of the Relative Valuation is (33.87) - (31.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 33.2x | 27.5x |
| Forward P/E multiples | 20.7x - 24.0x | 21.8x |
| Fair Price | (33.87) - (31.70) | (32.61) |
| Upside | -630.8% - -596.8% | -611.1% |
| Date | P/E |
| 2024-12-10 | -5.07 |
| 2024-12-09 | -4.87 |
| 2024-12-06 | -4.74 |
| 2024-12-05 | -4.59 |
| 2024-12-04 | -4.64 |
| 2024-12-03 | -4.76 |
| 2024-12-02 | -4.94 |
| 2024-11-29 | -4.49 |
| 2024-11-27 | -4.33 |
| 2024-11-26 | -4.29 |
| 2024-11-25 | -4.22 |
| 2024-11-22 | -3.55 |
| 2024-11-21 | -3.30 |
| 2024-11-20 | -3.34 |
| 2024-11-19 | -3.39 |
| 2024-11-18 | -3.54 |
| 2024-11-15 | -3.84 |
| 2024-11-14 | -4.22 |
| 2024-11-13 | -4.42 |
| 2024-11-12 | -4.48 |
| 2024-11-11 | -4.91 |
| 2024-11-08 | -4.40 |
| 2024-11-07 | -4.26 |
| 2024-11-06 | -4.35 |
| 2024-11-05 | -4.22 |
| 2024-11-04 | -3.98 |
| 2024-11-01 | -4.01 |
| 2024-10-31 | -3.66 |
| 2024-10-30 | -3.82 |
| 2024-10-29 | -3.56 |
| 2024-10-28 | -3.53 |
| 2024-10-25 | -3.36 |
| 2024-10-24 | -3.42 |
| 2024-10-23 | -3.57 |
| 2024-10-22 | -3.55 |
| 2024-10-21 | -3.44 |
| 2024-10-18 | -3.54 |
| 2024-10-17 | -3.51 |
| 2024-10-16 | -3.63 |
| 2024-10-15 | -3.76 |
| 2024-10-14 | -3.74 |
| 2024-10-11 | -3.73 |
| 2024-10-10 | -3.71 |
| 2024-10-09 | -3.78 |
| 2024-10-08 | -3.97 |
| 2024-10-07 | -4.09 |
| 2024-10-04 | -4.17 |
| 2024-10-03 | -3.82 |
| 2024-10-02 | -3.89 |
| 2024-10-01 | -3.79 |